Engineering HIV-Resistant, Anti-HIV Chimeric Antigen Receptor T Cells

The treatment or cure of HIV infection by cell and gene therapy has been a goal for decades. Recent advances in both gene editing and chimeric antigen receptor (CAR) technology have created new therapeutic possibilities for a variety of diseases. Broadly neutralizing monoclonal antibodies (bNAbs) wi...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Mol Ther
Autors principals: Hale, Malika, Mesojednik, Taylor, Romano Ibarra, Guillermo S., Sahni, Jaya, Bernard, Alison, Sommer, Karen, Scharenberg, Andrew M., Rawlings, David J., Wagner, Thor A.
Format: Artigo
Idioma:Inglês
Publicat: American Society of Gene & Cell Therapy 2017
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5363191/
https://ncbi.nlm.nih.gov/pubmed/28143740
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ymthe.2016.12.023
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars